GOING MAINSTREAM:
California City Council Decriminalizes Psychedelics!
For several years running, investors have capitalized on Canada’s full legalization of marijuana, as well as cannabis 2.0, in which derivatives (edibles and topical) were brought to market. There’s still plenty of gas left in the tank for cannabis companies, but it’s not the ground floor opportunity that it was in 2015-2018.
Most cannabis companies’ business models depend wholly on growth in the cannabis market; it’s rare to find a truly diversified and cutting-edge company; practically every cannabis angle has been covered already. To stand out from the rest would require proprietary technologies and formulas – and better yet, a new market to uncover and bring to the public.
A brand-new market is, in fact, emerging right now as regulations surrounding psilocybin or magic mushrooms are being relaxed or eliminated. Just as the power of the hemp plant was officially recognized by the federal government with the Farm Bill, a major city in California is now opening the door to the unexplored profit potential of the magic mushroom medicinal market.
In a landmark unanimous decision, the Santa Cruz City Council unanimously voted to effectively decriminalize a wide range of psychedelics, and that would include these magic mushrooms. A similar city council measure was previously approved in Oakland, while psilocybin mushrooms were decriminalized by a vote in May of last year.
This grassroots movement is clearly gaining momentum, and the Santa Cruz vote was a major coup for the pro-plant reformists. This is terrific news for people dealing with mental health issues, alcoholism, depression, and other conditions that magic mushrooms have shown potential to alleviate.
It’s also tremendous news for investors in Yield Growth Corp. (CSE: BOSS & US: BOSQF), as this company has the first-mover advantage in the nascent psychedelic medicine movement. Debt-free and stacked with proven executives from multiple industries, Yield Growth is perfectly positioned to take a big piece of the pie in this $4.2 trillion global wellness market.
Shares are up nearly 50% in JANUARY 2020 ALONE!
Penny White, the co-founder, CEO, and president of Yield Growth Corp., has over two decades of experience in building successful companies and started this company in the mega-successful cannabis niche but is now pioneering the magic mushroom market through this fast-expanding company.
She recognized the incredible healing potential of this unfairly maligned medical treatment that was criminalized in the 1960s but is now, much like marijuana, on the precipice of decriminalization. Today, Ms. White’s company controls over 200 proprietary cannabis product formulas and has a dozen patents pending, along with 145 formulas for edible mushroom products.
All of Yield Growth’s products are based on formulations that are developed in-house: the products are made locally in Vancouver, but their distribution system spans the globe. In the U.S. market, Yield Growth has generated robust revenues by selling its THC products in Oregon, one of the world’s oldest legalized cannabis markets.
Yield Growth’s subsidiary, Flourish Mushroom Labs, has already acquired the formulas for multiple medicinal mushroom products, including ready-to-eat packaged food products: soups, coffees, teas, hot cocoa, elixirs, and truffles, all to be mixed with healthy mushrooms.
With the global edible mushroom market expected to grow at a CAGR of 7.95% and reach $62 billion by 2023, Flourish could be Yield Growth’s most reliable revenue generator in the coming years – and a big winner for shareholders because the plant power movement now includes not only cannabis, but mushrooms as well.
Get updates on The Yield Growth Corp. and
more Wealth Building Ideas for the new economy.
Disclaimer
Legal Notice:
No matter how good an investment sounds, and no matter who is selling it, make sure you’re dealing with a registered investment professional. Use the free, simple search at investor.gov
This work is based on public filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.
Never base any decision off of our advertorials. Wallace Hill LTD (WealthResearchGroup.com) stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish. Please do your own research before investing. It is crucial that you at least look at current SEDAR filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with SEDAR under the company’s profile, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. We have been compensated by The Yield Growth four hundred and fifty thousand dollars for an active digital marketing agreement. We could be paid up to an additional four hundred and fifty thousand dollars in three quarterly payments of one hundred a fifty thousand. We have also recently participated in a private placement and own shares of the company with a four month hold on other trading restrictions. We will not sell shares within thirty days of any email coverage. We will never sell any shares during any active email coverage. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at wealthresearchgroup.com/disclaimer